| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |